NCT07460765 Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) Status NOT_YET_RECRUITING Phase PHASE1
NCT07241273 SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer Status NOT_YET_RECRUITING Phase NA
NCT03268993 Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer Status COMPLETED Phase NA
NCT03053310 Value of Geriatric Screening to Predict Postoperative Morbidity for Head and Neck Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01693718 A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00661427 Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer Status COMPLETED Phase PHASE2